Imago Biosciences Analysis

Imago Stock Analysis Notes

About 96.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.16. Imago Biosciences had not issued any dividends in recent years. Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1, an enzyme that used in the production of blood cells in the bone marrow. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Imago Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. To learn more about Imago Biosciences call MD Rienhoff at 415 529 5055 or check out https://www.imagobio.com.

Imago Biosciences Investment Alerts

Imago Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Imago Biosciences's market, we take the total number of its shares issued and multiply it by Imago Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Imago Biosciences Technical and Predictive Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how Imago Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Imago shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Imago Biosciences. By using and applying Imago Stock analysis, traders can create a robust methodology for identifying Imago entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Imago Biosciences information on this page should be used as a complementary analysis to other Imago Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

If you are still planning to invest in Imago Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Imago Biosciences' history and understand the potential risks before investing.